Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.

被引：0
作者：
She, Q.-B.
Chandarlapaty, S.
Ye, Q.
Lobo, J.
Haskell, K. M.
Leander, K. R.
DeFeo-Jones, D.
Huber, H. E.
Rosen, N.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Merck Res Labs, West Point, PA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
[21]   Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer [J].
Hanker, Ariella B. ;
Estrada, Monica Valeria ;
Bianchini, Giampaolo ;
Moore, Preston D. ;
Zhao, Junfei ;
Cheng, Feixiong ;
Koch, James P. ;
Gianni, Luca ;
Tyson, Darren R. ;
Sanchez, Violeta ;
Rexer, Brent N. ;
Sanders, Melinda E. ;
Zhao, Zhongming ;
Stricker, Thomas P. ;
Arteaga, Carlos L. .
CANCER RESEARCH, 2017, 77 (12) :3280-3292
[22]   Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients [J].
Kallergi, Galatea ;
Agelaki, Sofia ;
Kalykaki, Antonia ;
Stournaras, Christos ;
Mavroudis, Dimitris ;
Georgoulias, Vassilis .
BREAST CANCER RESEARCH, 2008, 10 (05)
[23]   Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients [J].
Galatea Kallergi ;
Sofia Agelaki ;
Antonia Kalykaki ;
Christos Stournaras ;
Dimitris Mavroudis ;
Vassilis Georgoulias .
Breast Cancer Research, 10
[24]   Activated PI3K and RTK signaling and response/resistance to HER2 targeted therapy [J].
O'Brien, Neil ;
Browne, Brigid ;
Chow, Lucy ;
Ginther, Charles ;
Bensadigh, Brian ;
Atefi, Mohammad ;
Arboleda, Jane ;
Duffy, Michael ;
Crown, John ;
O'Donovan, Norma ;
Slamon, Dennis .
CANCER RESEARCH, 2009, 69
[25]   HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells [J].
Christiane Knuefermann ;
Yang Lu ;
Bolin Liu ;
Weidong Jin ;
Ke Liang ;
Ling Wu ;
Mathias Schmidt ;
Gordon B Mills ;
John Mendelsohn ;
Zhen Fan .
Oncogene, 2003, 22 :3205-3212
[26]   PI3K/Akt signaling in osteosarcoma [J].
Zhang, Jian ;
Yu, Xiao-Hua ;
Yan, Yi-Guo ;
Wang, Cheng ;
Wang, Wen-Jun .
CLINICA CHIMICA ACTA, 2015, 444 :182-192
[27]   HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells [J].
Knuefermann, C ;
Lu, Y ;
Liu, BL ;
Jin, WD ;
Liang, K ;
Wu, L ;
Schmidt, M ;
Mills, GB ;
Mendelsohn, J ;
Fan, Z .
ONCOGENE, 2003, 22 (21) :3205-3212
[28]   PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells [J].
Navaei, Zahra Nasrpour ;
Khalili-Tanha, Ghazaleh ;
Zangouei, Amir Sadra ;
Abbaszadegan, Mohammad Reza ;
Moghbeli, Meysam .
ONCOLOGY RESEARCH, 2021, 29 (04) :235-250
[29]   HER2 amplification is associated with higher tumor mutation burden in breast cancer [J].
Yin, Y. ;
Li, W. ;
Huang, X. ;
Wu, H. ;
Zhang, Y. ;
Cai, S. ;
Zhou, S. .
ANNALS OF ONCOLOGY, 2018, 29
[30]   Divergent activation of AKT1 and AKT2 isoforms downstream of PI3K mutation impacts response of breast cancer cells to estradiol and PI3K inhibitors [J].
Nakshatri, Harikrishna ;
Goswami, Chirayu ;
Badve, Sunil ;
Magnani, Luca ;
Lupien, Mathieu ;
Bhat-Nakshatri, Poornima .
CANCER RESEARCH, 2015, 75
12345